Cargando…
Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
Hepatocellular carcinoma (HCC) is the 5(th) most frequently diagnosed cancer in the world, according to the World Health Organization. The incidence of HCC is between 3/100000 and 78.1/100000, with a high incidence reported in areas with viral hepatitis B and hepatitis C, thus affecting Asia and Afr...
Autor principal: | Balaceanu, Lavinia Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656675/ https://www.ncbi.nlm.nih.gov/pubmed/31363465 http://dx.doi.org/10.12998/wjcc.v7.i12.1367 |
Ejemplares similares
-
Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020) -
Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
por: Zhu, Kai, et al.
Publicado: (2013) -
Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023) -
New Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Yoshida, Katsunori
Publicado: (2015) -
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
por: Piñero, Federico, et al.
Publicado: (2020)